Novo Nordisk Total Liabilities

Novo Nordisk (NVO) currently reports a total liabilities of $360B as of March 2026. That compares with $350B in the prior-year period — up 1.6% year over year. Use the charts on this page to explore Novo Nordisk's total liabilities history and peer comparisons.

Novo Nordisk's total liabilities increased from $350B to $360B — a 1.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Novo Nordisk reported $360B in total liabilities as of March 2026. That compares with $350B in the prior-year period — up 1.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $360B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Novo Nordisk, and consider following NVO for alerts when major investors trade the stock.

Novo Nordisk is classified in the Healthcare sector. On total liabilities, it currently shows $360B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NVO with unrelated industries.